| Literature DB >> 29267506 |
Z J Zhang1, M L Zheng1, Y Nie1, Z Q Niu1.
Abstract
This study aimed to evaluate the feasibility and performance of Arndt-endobronchial blocker (Arndt) combined with laryngeal mask airway (LMA) compared with left-sided double-lumen endobronchial tube (L-DLT) in morbidly obese patients in one-lung ventilation (OLV). In a prospective, randomized double-blind controlled clinical trial, 80 morbidly obese patients (ASA I-III, aged 20-70) undergoing general anesthesia for elective thoracic surgeries were randomly allocated into groups Arndt (n=40) and L-DLT (n=40). In group Arndt, a LMA™ Proseal was placed followed by an Arndt-endobronchial blocker. In group L-DLT, patients were intubated with a left-sided double-lumen endotracheal tube. Primary endpoints were the airway establishment, ease of insertion, oxygenation, lung collapse and surgical field exposure. Results showed similar ease of airway establishment and tube/device insertion between the two groups. Oxygen arterial pressure (PaO2) of patients in the Arndt group was significantly higher than L-DLT (154±46 vs 105±52 mmHg; P<0.05). Quality of lung collapse and surgical field exposure in the Arndt group was significantly better than L-DLT (effective rate 100 vs 90%; P<0.05). Duration of surgery and anesthesia were significantly shorter in the Arndt group (2.4±1.7 vs 3.1±1.8 and 2.8±1.9 vs 3.8±1.8 h, respectively; P<0.05). Incidence of hoarseness of voice and incidence and severity of throat pain at the post-anesthesia care unit and 12, 24, 48, and 72 h after surgery were significantly lower in the Arndt group (P<0.05). Findings suggested that Arndt-endobronchial blocker combined with LMA can serve as a promising alternative for morbidly obese patients in OLV in thoracic surgery.Entities:
Mesh:
Year: 2017 PMID: 29267506 PMCID: PMC5734186 DOI: 10.1590/1414-431X20176825
Source DB: PubMed Journal: Braz J Med Biol Res ISSN: 0100-879X Impact factor: 2.590
Figure 1.CONSORT flow diagram. Arndt: Arndt-endobronchial blocker association; L-DLT: left-sided double-lumen endobronchial tube.
Criteria to assess endo-tracheal tube malpositions.
| • Bronchial cuff of the DLT herniated above tracheal carina (more than 50% of the cuff) |
| • Bronchial cuff edge of the DLT not visible in the entrance of mainstem bronchus such that it would potentially occlude a secondary bronchus |
| • Arndt blocker or DLT in the non-targeted bronchus |
| • Bronchial cuff of the Arndt blocker herniated into carina (more than 50% of the cuff), or the distal tip of the blocker above tracheal carina |
DLT: double-lumen endobronchial tube
Demographic characteristics, preoperative pulmonary functions and preoperative arterial blood gas values of the patients in the Arndt and L-DLT groups.
| Variables | Arndt group (n=40) | L-DLT group (n=40) |
|---|---|---|
| Age (year) | 59±12 | 60±11 |
| Gender (M/F) | 34/6 | 34/6 |
| Height (cm) | 166±6 | 165±7 |
| Weight (kg) | 114±11 | 115±10 |
| BMI (kg/m2) | 41.4±3 | 42.2±3 |
| Neck circumference (cm) | 44±4 | 45±5 |
| FEV1 (% predicted) | 78±13 | 79±14 |
| FRC (% predicted) | 135±18 | 135±19 |
| RV (% predicted) | 142±20 | 141±21 |
| TLC (% predicted) | 105±15 | 102±16 |
| Smoking history (n) | 21 | 20 |
| PaCO2 (mmHg, room air) | 39±2 | 40±2 |
| PaO2 (mmHg, room air) | 81±7 | 80±8 |
| O2sat (%) | 95.9±0.6 | 96.4±0.8 |
| PEEPi (cmH2O) | 3.1±0.2 | 3.0±0.4 |
| Pre-op BP (mmHg) | 135±22 | 133±21 |
| Pre-op HR (bpm) | 75±6 | 76±5 |
| Surgery duration (h) | 2.4±1.7 | 3.1±1.8 |
| Anesthesia duration (h) | 2.8±1.9 | 3.8±1.8 |
Data are reported as means±SD. n: number of patients; BMI: body mass index; FEV1: forced expiratory volume in 1s; FRC: functional residual capacity; RV: residual volume; TLC: total lung capacity; PEEPi: intrinsic positive end-expiratory pressure; Arndt: Arndt-endobronchial blocker association; L-DLT: left-sided double-lumen endobronchial tube.
P<0.05 Arndt group compared with L-DLT group (t-test).
Type of thoracic surgery and related outcomes of the 80 patients and airway parameters.
| Type of procedure | Arndt group (n-40) | L-DLT group (n=40) | P value |
|---|---|---|---|
| Lobectomy | 0.36 | ||
| Right-sided | 16 | 14 | |
| Left-sided | 8 | 10 | |
| Pneumonectomy | |||
| Right-sided | 1 | 0 | |
| Left-sided | 1 | 2 | |
| Upper and middle esophageal resection | 14 | 14 | |
| Airway parameters | |||
| Mallampati grade | 2.1±1.1 | 2.2±1.2 | 0.78 |
| Cormack grade | 2.2±1.3 | 2.3±1.2 | 0.68 |
| Intubation attempts (n) | 1.1±0.1 | 1.1±0.2 | 0.56 |
| First attempt (n) | 37 | 36 | |
| Second attempt (n) | 3 | 3 | |
| Third attempt (n) | 0 | 1 | |
| Intubation duration (min) | 3.3±0.4 | 3.4±0.5 | 0.84 |
| Positioning attempts (n) | 1.1±0.1 | 1.1±0.1 | 0.81 |
| Number of malpositions (n) | 3 | 3 | |
| Positioning duration (min) | 4.4±0.6 | 3.2±0.4 | 0.92 |
| Adjustments (n) | 0.6±0.2 | 0.4±0.1 | 0.35 |
Data are reported as mean±SD or number of patients. Arndt: Arndt-endobronchial blocker association; L-DLT: left-sided double-lumen endobronchial tube. Statistical analysis was done with the t-test.
Gas exchange data of the 80 patients during OLV.
| Variables | OLV | |
|---|---|---|
| Arndt group (n=40) | L-DLT group (n=40) | |
| Ppeak (cmH2O) | 24±3 | 23±4 |
| Pplateau (cmH2O) | 16±2 | 15±2 |
| PEEPi (cmH2O) | 2.5±0.3 | 2.0±0.4 |
| PaCO2 (mmHg) | 39±5 | 38±5 |
| PaO2 (mmHg) | 154±46 | 105±52 |
| P(A-a)O2 (mmHg) | 194±42 | 243±45 |
Data are reported as means±SD. n: number of patients; OLV: one lung ventilation; Ppeak: peak inspiratory airway pressure; Pplateau: end-inspiratory airway pressure; PEEPi: intrinsic positive end-expiratory pressure; P(A-a)O2: alveolar-arterial oxygen tension difference; Arndt: Arndt-endobronchial blocker association; L-DLT: left-sided double-lumen endobronchial tube.
P<0.05 (t-test).
Incidence of hoarseness of voice, incidence of throat pain and throat pain score among the 80 patients at PACU and 12, 24, 48, 72, and >72 h after thoracic surgery.
| Hoarseness of voice | Throat pain | Throat pain score by numerical rating scale (NRS) | ||||||
|---|---|---|---|---|---|---|---|---|
| Arndt (n, %) | L-DLT (n, %) | Arndt (n, %) | L-DLT (n, %) | Arndt group | L-DLT group | |||
| Mean | Maximum | Mean | Maximum | |||||
| PACU | 3 (7.5%) | 9 (22.5%) | 6 (15%) | 13 (32.5%) | 2 | 3 | 5 | 6 |
| 12 h | 4 (10%) | 12 (30%) | 8 (20%) | 17 (42.5%) | 3 | 4 | 7 | 8 |
| 24 h | 3 (7.5%) | 10 (25%) | 7 (17.5%) | 15 (37.5%) | 2 | 3 | 5 | 7 |
| 48 h | 2 (5%) | 7 (17.5%) | 5 (12.5%) | 13 (32.5%) | 1 | 2 | 3 | 5 |
| 72 h | 1 (2.5%) | 4 (10%) | 1 (2.5%) | 7 (17.5%) | 0.25 | 1 | 2 | 3 |
| >72 h | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 | 0 | 0 | 0 |
Data are reported as number and percentage. PACU: Post anesthesia care unit; Arndt total number of patients = 40; L-DLT total number of patients = 40. Arndt: Arndt-endobronchial blocker association; L-DLT: left-sided double-lumen endobronchial tube.
P<0.05 (t-test).